The only dedicated veterinary center providing this treatment is in Malvern, Pennsylvania. CyberKnife technology has evolved and can be a quick and easier treatment for our four-legged friends.

NHS England has been branded 'scandalous' after it emerged that five life saving cancer machines are not being replaced ...

CyberKnife radiosurgery is a 15-minute outpatient procedure that requires no anesthesia or hospital admission, offering a non ...

The 2025 National Inventors Hall of Fame Induction Ceremony is sponsored by the USPTO; Qualcomm; Ted and Judy Hoff; PhRMA; The Amos E. Joel Young Inventors Fund; Mary Beth Carroll and Dr. Keith Wilson ...

2023 Stud Fee: $30,000 32 offered, 25 sold, $2,556,000 gross, $102,240 average, $50,000 median Fillies: 25 sold, $102,240 avg ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Image Source: Zacks Investment Research Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic ...

President William Ruto has commissioned a cyberknife at the Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) which will be used to provide better health services for non ...

If there is any movement, the CyberKnife compensates for it. The robot is thus able to hit tumors with pinpoint accuracy, leaving healthy tissue undamaged. Spotlight on Robotics LBR MED ...

Accuray delivers solid fiscal second-quarter results, witnessing growth in Product revenues and reduced operating expenses.

Neurosurgeon John Adler invented the CyberKnife stereotactic radiosurgery (SRS) system, which enabled precision robotic, image-guided therapeutic radiation without skeletal fixation. Today ...

Asian Hospital is expected to cement its position as a leading cancer care facility with the launch of the Cyberknife later this year. AHMC’s new leaders, Dr. Maria Carmen Nievera, Chief Medical ...

The TrueBeam Linear Accelerator's RapidArc technology is effective in treating diseases such as breast cancer, prostate cancer, lung, head and neck cancer. It has the ability to target the tumour ...